GE Healthcare Technologies, Inc. (GEHC)
84.02
+1.00
(+1.21%)
USD |
NASDAQ |
Feb 20, 15:23
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 38.29B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -10.12% |
| Valuation | |
| PE Ratio | 18.45 |
| PE Ratio (Forward) | |
| PS Ratio | 1.865 |
| Price to Book Value | 3.689 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.035 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 1.008 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment provides scanning devices, clinical applications, service capabilities, and digital solutions. The AVS segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The PCS segment specializes in providing medical devices, consumables, services, and digital solutions. The PDx segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded in 1892. It was incorporated on May 16, 2022 and is headquartered in Chicago, IL. |
| URL | http://www.gehealthcare.com |
| Investor Relations URL | https://investor.gehealthcare.com/ |
| HQ State/Province | Illinois |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Apr. 29, 2026 (est.) |
| Last Earnings Release | Feb. 04, 2026 |
| Next Ex-Dividend Date | Apr. 02, 2026 |
| Last Ex-Dividend Date | Jan. 09, 2026 |
Profile
| GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment provides scanning devices, clinical applications, service capabilities, and digital solutions. The AVS segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The PCS segment specializes in providing medical devices, consumables, services, and digital solutions. The PDx segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded in 1892. It was incorporated on May 16, 2022 and is headquartered in Chicago, IL. |
| URL | http://www.gehealthcare.com |
| Investor Relations URL | https://investor.gehealthcare.com/ |
| HQ State/Province | Illinois |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Apr. 29, 2026 (est.) |
| Last Earnings Release | Feb. 04, 2026 |
| Next Ex-Dividend Date | Apr. 02, 2026 |
| Last Ex-Dividend Date | Jan. 09, 2026 |